Company news
Shanghai General Healthy Information & Technology Co. Ltd. Class A (SSE:605186) news
Shanghai General Healthy Information & Technology Co. Ltd. Class A news releases on 6ix. Latest, Sep 1, 2026: "Shanghai General Healthy Information…
View Shanghai General Healthy Information & Technology Co. Ltd. Class A →
Press releases & updates
"Shanghai General Healthy Information and Technology Co., Ltd."Announcement on Convening the 2026 Semi-annual Performance Briefing
August 31, 2026
"Shanghai General Healthy Information and Technology Co., Ltd."Special Report on the Deposit, Management and Actual Use of Raised Funds for the First Half of 2026
August 27, 2026
"Shanghai General Healthy Information and Technology Co., Ltd."Announcement on Reply to the Shanghai Stock Exchange's Information Disclosure Supervisory Inquiry Letter on the Company's 2025 Annual Report
July 30, 2026
"Shanghai General Healthy Information and Technology Co., Ltd."Announcement on Abnormal Fluctuations in Stock Trading
July 21, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
June 26, 2026
Announcement on Completion of Share Transfer of Ownership by Company Shareholders under Shareholder Agreement
June 12, 2026
Notice on Convening the 2025 Annual General Meeting
June 4, 2026
Indicative Announcement on Transfer of Shares under Agreement by Shareholders and Equity Changes
May 11, 2026
2025 Annual Report
April 28, 2026
Announcement on Progress in Acquisition of Partial Equity in Its Subsidiary Boko Guoxin (Wuhan) Technology Co., Ltd. and Completion of Industrial and Commercial Change Registration
April 14, 2026
Announcement on the 2025 Annual and Q1 2026 Performance and Cash Dividend Briefing
April 8, 2026
Announcement on Progress in Acquisition of Partial Equity in Its Subsidiary Boko Guoxin (Wuhan) Technology Co., Ltd.
February 27, 2026
Announcement on Resolutions of the 12th Meeting of the 3rd Board of Directors
February 5, 2026
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025
November 21, 2025
Announcement on Opening a Special Account for Raised Funds and Signing a Tripartite Supervision Agreement on Special Account Deposit of Raised Funds
November 20, 2025
Announcement on Change of Sponsor Representative for Continuous Supervision
November 14, 2025
Announcement on Adding Extraordinary Proposal Supplementary Notice of the 1st Extraordinary General Meeting in 2025
November 7, 2025
Announcement on SSE’s Reply to Letter of Supervision and Inquiry on Information of 2025 Semi-annual Report
November 5, 2025
Announcement on Resolutions of the 10th Meeting of the 3rd Board of Directors
November 3, 2025
Announcement on Convening the Q3 2025 Performance Briefing
October 31, 2025
Notice on Convening the 1st Extraordinary General Meeting in 2025
October 29, 2025
Announcement on Returning Using Partial Idle Raised Funds to Temporarily Supplement Current Capital
October 20, 2025
Announcement on Convening the 2025 Semi-annual Performance Briefing
September 1, 2025
Announcement on Making Provisions for Asset Impairment for the Half-Year Period of 2025
August 27, 2025
2025 Semi-annual Report
August 26, 2025
Announcement on Transfer of Partial Private Equity Investment Fund Shares
July 24, 2025
Semi-annual Earnings Preannouncement for 2025
July 14, 2025
Announcement on Appointment of Securities Affairs Representative
June 25, 2025
Notice on Convening the 2024 Annual General Meeting
June 4, 2025
Announcement on Estimated External Guarantee Amount in 2025
April 29, 2025
Announcement on Postponing Some Investment Projects Financed by Raised Funds
March 11, 2025
Announcement on Resignation of Independent Director Upon Expiration of Term of Office
March 3, 2025
Announcement on Progress in Participating in Investment in Private Fund
December 27, 2024
Announcement on Convening the Q3 2024 Performance Briefing
November 12, 2024
Announcement on Abnormal Fluctuations in Stock Trading
November 4, 2024
Announcement on Making Provisions for Asset Impairment in Q1-Q3 2024
October 30, 2024
Announcement on Return of Some Idle Raised Funds Used to Temporarily Supplement Working Capital
October 22, 2024
Announcement on Convening Semi-annual Performance Briefing 2024
September 3, 2024
Special Report on Semi-annual Deposit and Actual Use of Raised Funds in 2024
August 30, 2024
Announcement on Implementation of Dividend Distribution for 2023
August 18, 2024
Announcement on Resolutions of 2023 Annual General Meeting
June 27, 2024
Notice on Convening 2023 Annual General Meeting
June 5, 2024
Announcement on Convening 2023 Annual Performance and Cash Dividend Meeting
June 3, 2024
Announcement on Progress in Signing Strategic Cooperation Agreement for "Smart Pharmacy"
May 20, 2024
Announcement on Estimated Amount of Outward Guarantees in 2024
April 29, 2024
Signing Strategic Cooperation Agreement with MEDSNAB-GROUP LLC Company in Russia
April 25, 2024
Announcement on Resolutions of 1st Special Shareholders' Meeting of 2024
April 11, 2024